SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.43-0.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg6/6/2007 6:42:25 AM
   of 2240
 
Vanda Names New Board Member
Tuesday June 5, 6:08 pm ET
Vanda Names Howard H. Pien to Replace Departing Board Member James B. Tananbaum

[Leaves a bad taste in my mouth. There should be enough at Medarex for the next couple of years for Pien, if he is serious about the job. And Vanda is not a company that inspires a lot of confidence. I hope Pien will not morph into a DD Mark II].

ROCKVILLE, Md. (AP) -- Biopharmaceutical company Vanda Pharmaceuticals Inc. said Tuesday it named Howard H. Pien to replace James B. Tananbaum on the company's board.

Pien will also take Tananbaum's place on the board's compensation committee, Vanda said.

A reason was not given for Tananbaum's departure. He has been a board director since 2004, Vanda said.

Pien was recently named chief executive and president of biopharmaceutical company Medarex Inc.

Vanda's shares lost 9 cents in after-hours trading after finishing regular trading up 23 cents at $21.39.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext